Alterations in B-cell subsets in pediatric patients with early atopic dermatitis
- PMID: 27965110
- DOI: 10.1016/j.jaci.2016.09.060
Alterations in B-cell subsets in pediatric patients with early atopic dermatitis
Abstract
Background: B cells undergo maturation and class-switching in response to antigen exposure and T-cell help. Early B-cell differentiation has not been defined in patients with early-onset atopic dermatitis (AD).
Objective: We sought to define the frequency of B-cell subsets associated with progressive B-cell maturation and IgE class-switching.
Methods: We studied 27 children and 34 adults with moderate-to-severe AD (mean SCORAD score, 55 and 65, respectively) and age-matched control subjects (15 children and 27 adults). IgD/CD27 and CD24/CD38 core gating systems and an 11-color flow cytometric panel were used to determine the frequencies of circulating B-cell subsets. Serum total and allergen-specific IgE (sIgE) levels were measured by using ImmunoCAP.
Results: Compared with adults, children showed T-cell predominance in the skin. Circulating CD19+CD20+ B-cell counts were lower in patients with pediatric AD than in control subjects (24% vs 33%, P = .04), whereas CD3+ T-cell counts were higher (62% vs 52%, P = .05). A decreased B-cell/T-cell lymphocyte ratio with age was observed only in pediatric control subjects (r = -0.48, P = .07). In pediatric patients with AD, a positive correlation was observed between B-cell/T-cell ratio and nonswitched memory B-cell counts (r = 0.42, P = .03). Higher frequencies of positive sIgE levels were seen in pediatric patients with AD (P < .0001). Diverse sIgE levels correlated with SCORAD scores and age of pediatric patients with AD (P < .01). Positive correlations were observed between activated B-cell and memory T-cell counts (P < .02). In patients with AD, IgE sensitization to most allergens clustered with age, TH1, TH2, total IgE levels, and B-cell memory subsets.
Conclusions: Peripheral B and T cells are altered in pediatric patients with early AD, but T cells predominate in skin lesions.
Keywords: Atopic dermatitis; B cells; T cells; allergen-specific IgE; atopic march.
Copyright © 2016 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Evolution of pathologic B-cell subsets and serum environment-specific sIgEs in patients with atopic dermatitis and controls, from infancy to adulthood.Allergy. 2024 Oct;79(10):2732-2747. doi: 10.1111/all.16225. Epub 2024 Jul 14. Allergy. 2024. PMID: 39003573
-
Diverse activation and differentiation of multiple B-cell subsets in patients with atopic dermatitis but not in patients with psoriasis.J Allergy Clin Immunol. 2016 Jan;137(1):118-129.e5. doi: 10.1016/j.jaci.2015.08.027. Epub 2015 Oct 5. J Allergy Clin Immunol. 2016. PMID: 26441226
-
Severe atopic dermatitis is characterized by selective expansion of circulating TH2/TC2 and TH22/TC22, but not TH17/TC17, cells within the skin-homing T-cell population.J Allergy Clin Immunol. 2015 Jul;136(1):104-115.e7. doi: 10.1016/j.jaci.2015.01.020. Epub 2015 Mar 3. J Allergy Clin Immunol. 2015. PMID: 25748064
-
Circulating CLA+ T cells in atopic dermatitis and their possible role as peripheral biomarkers.Allergy. 2017 Mar;72(3):366-372. doi: 10.1111/all.13080. Epub 2016 Dec 15. Allergy. 2017. PMID: 27861978 Review.
-
Regulation of allergic inflammation by skin-homing T cells in allergic eczema.Int Arch Allergy Immunol. 1999 Feb-Apr;118(2-4):140-4. doi: 10.1159/000024051. Int Arch Allergy Immunol. 1999. PMID: 10224362 Review.
Cited by
-
Insights Into the Molecular Mechanisms of T Follicular Helper-Mediated Immunity and Pathology.Front Immunol. 2018 Aug 15;9:1884. doi: 10.3389/fimmu.2018.01884. eCollection 2018. Front Immunol. 2018. PMID: 30158933 Free PMC article. Review.
-
Evolution of pathologic B-cell subsets and serum environment-specific sIgEs in patients with atopic dermatitis and controls, from infancy to adulthood.Allergy. 2024 Oct;79(10):2732-2747. doi: 10.1111/all.16225. Epub 2024 Jul 14. Allergy. 2024. PMID: 39003573
-
Treatments for Childhood Atopic Dermatitis: an Update on Emerging Therapies.Clin Rev Allergy Immunol. 2021 Oct;61(2):114-127. doi: 10.1007/s12016-020-08799-1. Clin Rev Allergy Immunol. 2021. PMID: 32607924 Review.
-
Evaluation of Leukocytes, B and T Lymphocytes, and expression of CD200 and CD23 on B lymphocytes in Patients with Atopic Dermatitis on Dupilumab Therapy-Pilot Study.Dermatol Ther (Heidelb). 2023 May;13(5):1171-1192. doi: 10.1007/s13555-023-00918-y. Epub 2023 Apr 25. Dermatol Ther (Heidelb). 2023. PMID: 37097547 Free PMC article.
-
Genetic and Immunological Pathogenesis of Atopic Dermatitis.J Invest Dermatol. 2024 May;144(5):954-968. doi: 10.1016/j.jid.2023.10.019. Epub 2023 Dec 11. J Invest Dermatol. 2024. PMID: 38085213 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials